Delcath Adds University of Pittsburgh Medical Center to Phase III Trial -
Delcath Systems Granted Orphan-Drug Designations for Cutaneous and Ocular Melanoma -
DCTH: To Present At Rodman & Renshaw Investment Conference @ 15:15 ET [delayed] -
Delcath Systems to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference -
Delcath Systems Adds to Board -
Delcath Systems' President and CEO Richard Taney to Present at Two Medical Technology Conferences -
Delcath Systems names new board member -
Investigator Presents on Delcath Systems Phase III Trial Experience -
Delcath adds Providence Cancer Center to Phase III melanoma trial -
Delcath Adds Providence Cancer Center to Phase III Trial -
DCTH: Conference call regarding to Host Quarterly Update Conference Call @ 16:30 ET Today [delayed] -
Delcath Cancer Trials Welcome New Principal Investigator From NCI -
Delcath Systems to Host Quarterly Update Conference Call -
Swedish Medical joins Delcath's Phase III melanoma trial -
JWCI in California joins Delcath's Phase III metastatic melanoma trial -
DCTH: To Present At Canaccord Adams Global Growth Conference @ 10:30 ET [delayed] -